Literature DB >> 8448594

Effects of capsaicin and 5-HT3 antagonists on 5-hydroxytryptamine-evoked release of calcitonin gene-related peptide in the guinea-pig heart.

M Tramontana1, S Giuliani, E Del Bianco, A Lecci, C A Maggi, S Evangelista, P Geppetti.   

Abstract

1. The effect of 5-hydroxytryptamine (5-HT) on the release of calcitonin gene-related peptide (CGRP) was studied directly in the isolated perfused heart and indirectly in the isolated left atria of guinea-pig. 2. 5-HT injection into the guinea-pig isolated and perfused heart evoked a dose-dependent (1-100 microM) release of CGRP-like immunoreactivity (LI) that was abolished by in vitro pretreatment with capsaicin and was not affected by indomethacin. 3. Chlorophenyldiguanide (CPD, 100 microM), but not 8-hydroxy-dipropylaminotetralin (8-OH-DPAT, 100 microM), sumatriptan (100 microM) or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI, 100 microM) evoked a release of CGRP-LI. Ondansetron (10 microM) or ICS205-930 (20 microM) completely abolished the 5-HT (100 microM)-evoked CGRP-LI release. 4. In the isolated electrically driven left atria of the guinea-pig 5-HT (1-10 microM) and CPD (3-100 microM) produced a positive inotropic response, which was abolished by capsaicin pretreatment. 8-OH-DPAT (10 microM) and DOI (10 microM) were inactive. Ondansetron inhibited the response to 5-HT with a pA2 of 6.50 (CL 6.08-6.91). 5. It is concluded that 5-HT causes a release of CGRP in the whole heart and a positive inotropic response in the isolated atria of guinea-pig. Both these effects are sensitive to capsaicin pretreatment and to 5-HT3 antagonists.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448594      PMCID: PMC1907963          DOI: 10.1111/j.1476-5381.1993.tb12821.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart.

Authors:  P Geppetti; C A Maggi; F Perretti; S Frilli; S Manzini
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

2.  Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.

Authors:  A Butler; J M Hill; S J Ireland; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

Review 3.  Role of cardiac vagal C-fibers in cardiovascular control.

Authors:  P Thorén
Journal:  Rev Physiol Biochem Pharmacol       Date:  1979       Impact factor: 5.545

4.  Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

Authors:  P B Bradley; G Engel; W Feniuk; J R Fozard; P P Humphrey; D N Middlemiss; E J Mylecharane; B P Richardson; P R Saxena
Journal:  Neuropharmacology       Date:  1986-06       Impact factor: 5.250

5.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

Authors:  B P Richardson; G Engel; P Donatsch; P A Stadler
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

6.  Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones.

Authors:  G Jancsó; E Kiraly; A Jancsó-Gábor
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

7.  Specific receptor and cardiovascular effects of calcitonin gene-related peptide.

Authors:  S Sigrist; A Franco-Cereceda; R Muff; H Henke; J M Lundberg; J A Fischer
Journal:  Endocrinology       Date:  1986-07       Impact factor: 4.736

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Calcitonin gene-related peptide (CGRP) and capsaicin-induced stimulation of heart contractile rate and force.

Authors:  A Franco-Cereceda; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

10.  Calcitonin gene-related peptide as potential neurotransmitter in guinea pig right atrium.

Authors:  A Saito; S Kimura; K Goto
Journal:  Am J Physiol       Date:  1986-04
View more
  7 in total

1.  On the presence of serotonin in mammalian cardiomyocytes.

Authors:  Klaus Pönicke; Ulrich Gergs; Igor B Buchwalow; Steffen Hauptmann; Joachim Neumann
Journal:  Mol Cell Biochem       Date:  2012-02-25       Impact factor: 3.396

2.  Diverse inotropic effects of 5-hydroxytryptamine in heart muscles of various mammalian species.

Authors:  H Zaizen; S Imanishi; M Nasu; M Arita
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

3.  Characterization of the 5-hydroxytryptamine receptor mediating the positive inotropic response in guinea-pig isolated left atria.

Authors:  N Lattimer; P Gupta; K F Rhodes
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

Review 4.  Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

Authors:  Carlos M Villalón; David Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-17       Impact factor: 3.000

5.  Inhibition of excitatory non-adrenergic non-cholinergic bronchoconstriction in guinea-pig airways in vitro by activation of an atypical 5-HT receptor.

Authors:  J K Ward; A J Fox; P J Barnes; M G Belvisi
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

6.  Human 5-HT₄receptor stimulation in atria of transgenic mice.

Authors:  Ulrich Gergs; Anne Böckler; Henning Ebelt; Steffen Hauptmann; Nicolas Keller; Volker Otto; Klaus Pönicke; Wilhelm Schmitz; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-11       Impact factor: 3.000

7.  Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atrium.

Authors:  Ulrich Gergs; Joachim Neumann; Andreas Simm; Rolf-Edgar Silber; Freerk Ole Remmers; Stephanie Läer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-11       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.